Search Icon
CLRB Archived Articles

Cellectar Biosciences, Inc. (CLRB): Pioneering Targeted Radiotherapies to Transform Cancer Treatment

Published on November 30, 2024

Cellectar Biosciences, Inc. (NASDAQ:CLRB): A Promising Radiotherapeutic Pipeline Poised for Potential Breakthrough in Waldenstrom's Macroglobulinemia

Published on September 24, 2024